{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:04:06Z","timestamp":1777457046075,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00250981"],"award-info":[{"award-number":["RS-2023-00250981"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022M3E5E8081778"],"award-info":[{"award-number":["2022M3E5E8081778"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Kv1.3 channels in microglia are pivotal in regulating neuroinflammation. The antipsychotic chlorpromazine (CPZ) demonstrates anti-inflammatory effects by decreasing Kv1.3 activity in mPFC microglia. However, the precise mechanism of CPZ\u2019s effect in the mPFC remains unclear, given that CPZ is known to inhibit dopamine receptors and the mPFC contains various cell types with dopamine receptors. In this study, we investigate how CPZ inhibits Kv1.3 channels using human Kv1.3 channel-expressing <jats:italic>Xenopus laevis<\/jats:italic> oocytes. CPZ directly inhibits Kv1.3 channel currents in a concentration-dependent manner. The CPZ-mediated Kv1.3 channel inhibition is not voltage-dependent, and CPZ accelerates Kv1.3 channel inactivation without significantly affecting its activation. Our findings suggest that CPZ directly blocks Kv1.3 channels without involving other ion channels or receptors, including dopamine receptors, thereby contributing to the understanding of its neuroinflammation-suppressing mechanism.<\/jats:p>","DOI":"10.1186\/s13041-025-01211-z","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:14:36Z","timestamp":1746706476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chlorpromazine directly inhibits Kv1.3 channels by facilitating the inactivation of channels"],"prefix":"10.1186","volume":"18","author":[{"given":"Seo-In","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soobeen","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soohyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junseo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Hyun","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"1211_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19:622\u201335.","journal-title":"Nat Rev Neurosci"},{"key":"1211_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuroscience.2015.05.018","volume":"300","author":"GZ Reus","year":"2015","unstructured":"Reus GZ, Fries GR, Stertz L, Badawy M, Passos IC, Barichello T, Kapczinski F, Quevedo J. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience. 2015;300:141\u201354.","journal-title":"Neuroscience"},{"key":"1211_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.1227901","volume":"339","author":"A Aguzzi","year":"2013","unstructured":"Aguzzi A, Barres BA, Bennett ML. Microglia: scapegoat, saboteur, or something else? Science. 2013;339:156\u201361.","journal-title":"Science"},{"key":"1211_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrneurol.2014.207","volume":"11","author":"X Hu","year":"2015","unstructured":"Hu X, Leak RK, Shi Y, Suenaga J, Gao Y, Zheng P, Chen J. Microglial and macrophage polarization-new prospects for brain repair. Nat Rev Neurol. 2015;11:56\u201364.","journal-title":"Nat Rev Neurol"},{"key":"1211_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/glia.22372","volume":"61","author":"T Blank","year":"2013","unstructured":"Blank T, Prinz M. Microglia as modulators of cognition and neuropsychiatric disorders. Glia. 2013;61:62\u201370.","journal-title":"Glia"},{"key":"1211_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, Das A, Ray SK, Banik NL. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87:10\u201320.","journal-title":"Brain Res Bull"},{"key":"1211_CR7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fncel.2018.00488","volume":"12","author":"S Bachiller","year":"2018","unstructured":"Bachiller S, Jimenez-Ferrer I, Paulus A, Yang Y, Swanberg M, Deierborg T, Boza-Serrano A. Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response. Front Cell Neurosci. 2018;12:488.","journal-title":"Front Cell Neurosci"},{"key":"1211_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41577-020-00487-7","volume":"21","author":"KE Zengeler","year":"2021","unstructured":"Zengeler KE, Lukens JR. Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders. Nat Rev Immunol. 2021;21:454\u201368.","journal-title":"Nat Rev Immunol"},{"key":"1211_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.tins.2018.12.007","volume":"42","author":"P Izquierdo","year":"2019","unstructured":"Izquierdo P, Attwell D, Madry C. Ion channels and receptors as determinants of microglial function. Trends Neurosci. 2019;42:278\u201392.","journal-title":"Trends Neurosci"},{"key":"1211_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104925","volume":"142","author":"L Luo","year":"2021","unstructured":"Luo L, Song S, Ezenwukwa CC, Jalali S, Sun B, Sun D. Ion channels and transporters in microglial function in physiology and brain diseases. Neurochem Int. 2021;142: 104925.","journal-title":"Neurochem Int"},{"key":"1211_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3233\/JAD-141704","volume":"44","author":"S Rangaraju","year":"2015","unstructured":"Rangaraju S, Gearing M, Jin L-W, Levey A. Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer\u2019s disease. J Alzheimers Dis. 2015;44:797\u2013808.","journal-title":"J Alzheimers Dis"},{"key":"1211_CR12","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.4049\/jimmunol.181.10.6803","volume":"181","author":"N Matzner","year":"2008","unstructured":"Matzner N, Zemtsova IM, Nguyen TX, Duszenko M, Shumilina E, Lang F. Ion channels modulating mouse dendritic cell functions. J Immunol. 2008;181:6803\u20139.","journal-title":"J Immunol"},{"key":"1211_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ddr.20467","volume":"72","author":"J Lam","year":"2011","unstructured":"Lam J, Wulff H. The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression. Drug Dev Res. 2011;72:573\u201384.","journal-title":"Drug Dev Res"},{"key":"1211_CR14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3389\/fnins.2019.01393","volume":"13","author":"X Wang","year":"2020","unstructured":"Wang X, Li G, Guo J, Zhang Z, Zhang S, Zhu Y, Cheng J, Yu L, Ji Y, Tao J. Kv1.3 channel as a key therapeutic target for neuroinflammatory diseases: state of the art and beyond. Front Neurosci. 2020;13:1393.","journal-title":"Front Neurosci"},{"key":"1211_CR15","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1523\/JNEUROSCI.1251-05.2005","volume":"25","author":"CB Fordyce","year":"2005","unstructured":"Fordyce CB, Jagasia R, Zhu X, Schlichter LC. Microglia Kv1.3 channels contribute to their ability to kill neurons. J Neurosci. 2005;25:7139\u201349.","journal-title":"J Neurosci"},{"key":"1211_CR16","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/glia.23457","volume":"66","author":"J Di Lucente","year":"2018","unstructured":"Di Lucente J, Nguyen HM, Wulff H, Jin L-W, Maezawa I. The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo. Glia. 2018;66:1881\u201395.","journal-title":"Glia"},{"key":"1211_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/glia.23078","volume":"65","author":"HM Nguyen","year":"2017","unstructured":"Nguyen HM, Gr\u00f6ssinger EM, Horiuchi M, Davis KW, Jin L-W, Maezawa I, Wulff H. Differential Kv1.3, KCa3.1, and Kir2.1 expression in \u201cclassically\u201d and \u201calternatively\u201d activated microglia. Glia. 2017;65:106\u201321.","journal-title":"Glia"},{"key":"1211_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/acn3.513","volume":"5","author":"Y-J Chen","year":"2018","unstructured":"Chen Y-J, Nguyen HM, Maezawa I, Jin L-W, Wulff H. Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke. Ann Clin Transl Neurol. 2018;5:147\u201361.","journal-title":"Ann Clin Transl Neurol"},{"key":"1211_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12974-017-0906-6","volume":"14","author":"S Rangaraju","year":"2017","unstructured":"Rangaraju S, Raza SA, Pennati A, Deng Q, Dammer EB, Duong D, Pennington MW, Tansey MG, Lah JJ, Betarbet R, Seyfried NT, Levey AI. A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation. J Neuroinflamm. 2017;14:128.","journal-title":"J Neuroinflamm"},{"key":"1211_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.3854","volume":"192","author":"I Creese","year":"1976","unstructured":"Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976;192:481\u20133.","journal-title":"Science"},{"key":"1211_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","volume":"17","author":"AA Grace","year":"2016","unstructured":"Grace AA. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci. 2016;17:524\u201332.","journal-title":"Nat Rev Neurosci"},{"key":"1211_CR22","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.2976","volume":"188","author":"LL Iversen","year":"1975","unstructured":"Iversen LL. Dopamine receptors in the brain. Science. 1975;188:1084\u20139.","journal-title":"Science"},{"key":"1211_CR23","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK, Clinical Antipsychotic Trials of Intervention Effectiveness. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209\u201323.","journal-title":"N Engl J Med"},{"key":"1211_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nrd3649","volume":"11","author":"J Pratt","year":"2012","unstructured":"Pratt J, Winchester C, Dawson N, Morris B. Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. Nat Rev Drug Discov. 2012;11:560\u201379.","journal-title":"Nat Rev Drug Discov"},{"key":"1211_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pnpbp.2007.06.031","volume":"32","author":"Q Bian","year":"2008","unstructured":"Bian Q, Kato T, Monji A, Hashioka S, Mizoguchi Y, Horikawa H, Kanba S. The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-\u03b3. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:42\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1211_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.euroneuro.2004.04.002","volume":"15","author":"K Labuzek","year":"2005","unstructured":"Labuzek K, Kowalski J, Gabryel B, Herman ZS. Chlorpromazine and loxapine reduce interleukin-1\u03b2 and interleukin-2 release by rat mixed glial and microglial cell cultures. Eur Neuropsychopharmacol. 2005;15:23\u201330.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1211_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","volume":"33","author":"H Sugino","year":"2009","unstructured":"Sugino H, Futamura T, Mitsumoto Y, Maeda K, Marunaka Y. Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:303\u20137.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1211_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2174\/138955711795906941","volume":"11","author":"TA Kato","year":"2011","unstructured":"Kato TA, Monji A, Mizoguchi Y, Hashioka S, Horikawa H, Seki Y, Kasai M, Utsumi H, Kanba S. Anti-inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a & #x27;fire extinguisher\u2019 in the brain of schizophrenia? Mini-Rev Med Chem. 2011;11:565\u201374.","journal-title":"Mini-Rev Med Chem"},{"key":"1211_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/glia.24629","volume":"73","author":"HY Lee","year":"2025","unstructured":"Lee HY, Lee Y, Chung C, Park SI, Shin HJ, Joe EH, Lee SJ, Kim DW, Jo SH, Choi SY. The antipsychotic chlorpromazine reduces neuroinflammation by inhibiting microglial voltage-gated potassium channels. Glia. 2025;73:210\u201327.","journal-title":"Glia"},{"key":"1211_CR30","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1016\/j.bbamem.2015.08.013","volume":"1848","author":"I Kazama","year":"2015","unstructured":"Kazama I, Ejima Y, Endo Y, Toyama H, Matsubara M, Baba A, Tachi M. Chlorpromazine-induced changes in membrane micro-architecture inhibit thrombopoiesis in rat megakaryocytes. Biochim Biophys Acta. 2015;1848:2805\u201312.","journal-title":"Biochim Biophys Acta"},{"key":"1211_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00210-015-1109-2","volume":"388","author":"J Yu","year":"2015","unstructured":"Yu J, Park MH, Choi SY, Jo SH. Cortisone and hydrocortisone inhibit human Kv1.3 activity in a non-genomic manner. Naunyn Schmiedebergs Arch Pharmacol. 2015;388:653\u201361.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1211_CR32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/sj.bjp.0705283","volume":"139","author":"D Thomas","year":"2003","unstructured":"Thomas D, Wu K, Kathofer S, Katus HA, Schoels W, Kiehn J, Karle CA. The antipsychotic drug chlorpromazine inhibits HERG potassium channels. Br J Pharmacol. 2003;139:567\u201374.","journal-title":"Br J Pharmacol"},{"key":"1211_CR33","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1471-4159.2008.05435.x","volume":"106","author":"T Kato","year":"2008","unstructured":"Kato T, Mizoguchi Y, Monji A, Horikawa H, Suzuki SO, Seki Y, Iwaki T, Hashioka S, Kanba S. Inhibitory effects of aripiprazole on interferon-\u03b3-induced microglial activation via intracellular Ca2+ regulation in vitro. J Neurochem. 2008;106:815\u201325.","journal-title":"J Neurochem"},{"key":"1211_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/svn-2016-000012","volume":"1","author":"H Liu","year":"2016","unstructured":"Liu H, Leak RK, Hu X. Neurotransmitter receptors on microglia. Stroke Vasc Neurol. 2016;1:52\u20138.","journal-title":"Stroke Vasc Neurol"},{"key":"1211_CR35","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/jcbfm.2015.128","volume":"35","author":"JH Huck","year":"2015","unstructured":"Huck JH, Freyer D, B\u00f6ttcher C, Mladinov M, Muselmann-Genschow C, Thielke M, Gladow N, Bloomquist D, Mergenthaler P, Priller J. De novo expression of dopamine D2 receptors on microglia after stroke. J Cereb Blood Flow Metab. 2015;35:1804\u201311.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1211_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41467-019-14173-3","volume":"11","author":"KE Linker","year":"2020","unstructured":"Linker KE, Gad M, Tawadrous P, Cano M, Green KN, Wood MA, Leslie FM. Microglial activation increases cocaine self-administration following adolescent nicotine exposure. Nat Commun. 2020;11:306.","journal-title":"Nat Commun"},{"key":"1211_CR37","first-page":"265","volume":"19","author":"S Kanba","year":"1994","unstructured":"Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G, Asai M, Richelson E. Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci. 1994;19:265\u20139.","journal-title":"J Psychiatry Neurosci"},{"key":"1211_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1742-2094-9-203","volume":"9","author":"PJ Gaskill","year":"2012","unstructured":"Gaskill PJ, Carvallo L, Eugenin EA, Berman JW. Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. J Neuroinflamm. 2012;9:203.","journal-title":"J Neuroinflamm"},{"key":"1211_CR39","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.4049\/jimmunol.1002475","volume":"186","author":"K Nakano","year":"2011","unstructured":"Nakano K, Yamaoka K, Hanami K, Saito K, Sasaguri Y, Yanagihara N, Tanaka S, Katsuki I, Matsushita S, Tanaka Y. Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis\/SCID mouse chimera model. J Immunol. 2011;186:3745\u201352.","journal-title":"J Immunol"},{"key":"1211_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11481-018-9825-2","volume":"14","author":"RA Nolan","year":"2019","unstructured":"Nolan RA, Muir R, Runner K, Haddad EK, Gaskill PJ. Role of macrophage dopamine receptors in mediating cytokine production: implications for neuroinflammation in the context of HIV-associated neurocognitive disorders. J Neuroimmune Pharmacol. 2019;14:134\u201356.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1211_CR41","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.bbih.2019.100030","volume":"2","author":"RA Nolan","year":"2020","unstructured":"Nolan RA, Reeb KL, Rong Y, Matt SM, Johnson HS, Runner K, Gaskill PJ. Dopamine activates NF-kappaB and primes the NLRP3 inflammasome in primary human macrophages. Brain Behav Immun Health. 2020;2:100030.","journal-title":"Brain Behav Immun Health"},{"key":"1211_CR42","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.1038\/s41598-022-09891-6","volume":"12","author":"K Wieber","year":"2022","unstructured":"Wieber K, Fleige L, Tsiami S, Reinders J, Braun J, Baraliakos X, Capellino S. Dopamine receptor 1 expressing B cells exert a proinflammatory role in female patients with rheumatoid arthritis. Sci Rep. 2022;12:5985.","journal-title":"Sci Rep"},{"key":"1211_CR43","doi-asserted-by":"publisher","first-page":"C1714","DOI":"10.1152\/ajpcell.00258.2006","volume":"292","author":"HS Ahn","year":"2007","unstructured":"Ahn HS, Kim SE, Choi BH, Choi JS, Kim MJ, Rhie DJ, Yoon SH, Jo YH, Kim MS, Sung KW, Kwon OJ, Hahn SJ. Calcineurin-independent inhibition of KV1.3 by FK-506 (tacrolimus): a novel pharmacological property. Am J Physiol Cell Physiol. 2007;292:C1714-1722.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1211_CR44","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/glia.23847","volume":"68","author":"HM Nguyen","year":"2020","unstructured":"Nguyen HM, di Lucente J, Chen Y-J, Cui Y, Ibrahim RH, Pennington MW, Jin L-W, Maezawa I, Wulff H. Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4-mediated calcium entry in microglia. Glia. 2020;68:2377\u201394.","journal-title":"Glia"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-025-01211-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-025-01211-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-025-01211-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:03:14Z","timestamp":1746709394000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-025-01211-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1211"],"URL":"https:\/\/doi.org\/10.1186\/s13041-025-01211-z","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were approved by the Institutional Animal Care and Use Committee of the Seoul National University and Kangwon National University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}